{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T05:19:36Z","timestamp":1735881576106,"version":"3.32.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,2]]},"DOI":"10.7759\/cureus.76787","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T13:04:15Z","timestamp":1735823055000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of B-cell Prolymphocytic Leukemia: The First Documented Diagnosis in Georgia With a Comprehensive Literature Review"],"prefix":"10.7759","author":[{"given":"Giorgi","family":"Maisuradze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgi","family":"Akhvlediani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elene","family":"Dzodzuashvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar","family":"Gersamia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maia","family":"Sturua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.14740\/jh1096","article-title":"De-novo B-cell prolymphocytic leukemia","volume":"12","author":"Menakuru SR","year":"2023","unstructured":"Menakuru SR, Roepke J, Siddiqui S. De-novo B-cell prolymphocytic leukemia. J Hematol. 2023, 12:82-6. 10.14740\/jh1096","journal-title":"J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5629","article-title":"B-cell prolymphocytic leukemia: case report and challenges on a diagnostic and therapeutic forefront","volume":"11","author":"Bindra BS","year":"2019","unstructured":"Bindra BS, Kaur H, Portillo S, Emiloju O, Garcia de de Jesus K. B-cell prolymphocytic leukemia: case report and challenges on a diagnostic and therapeutic forefront. Cureus. 2019, 11:e5629. 10.7759\/cureus.5629","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.6.2015","article-title":"p53 abnormalities in B-cell prolymphocytic leukemia","volume":"89","author":"Lens D","year":"1997","unstructured":"Lens D, De Schouwer PJJC, Hamoudi RA, et al.. p53 abnormalities in B-cell prolymphocytic leukemia. Am Soc Hematol. 1997, 89:2015-23. 10.1182\/blood.V89.6.2015","journal-title":"Am Soc Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-23-828","article-title":"B-cell prolymphocytic leukemia with P53 abnormalities successfully treated with bendamustine and rituximab: a report of three cases","volume":"12","author":"Wang A","year":"2023","unstructured":"Wang A, Guo W, Damiani D, Sumbly V, Goyal G, Du Z, Bai O. B-cell prolymphocytic leukemia with P53 abnormalities successfully treated with bendamustine and rituximab: a report of three cases. Transl Cancer Res. 2023, 12:1873-82. 10.21037\/tcr-23-828","journal-title":"Transl Cancer Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4322\/acr.2020.196","article-title":"De novo chronic lymphocytic leukemia\/prolymphocytic leukemia or B-cell prolymphocytic leukemia? The importance of integrating clinico-morphological and immunophenotypic findings in distinguishing chronic lymphoproliferative diseases with circulating phase","volume":"11","author":"Chowdhury Z","year":"2021","unstructured":"Chowdhury Z, Khonglah Y, Sarma S, Kalita P. De novo chronic lymphocytic leukemia\/prolymphocytic leukemia or B-cell prolymphocytic leukemia? The importance of integrating clinico-morphological and immunophenotypic findings in distinguishing chronic lymphoproliferative diseases with circulating phase. Autops Case Rep. 2021, 11:e2020196. 10.4322\/acr.2020.196","journal-title":"Autops Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-380139","article-title":"How I treat prolymphocytic leukemia","volume":"120","author":"Dearden C","year":"2012","unstructured":"Dearden C. How I treat prolymphocytic leukemia. Blood. 2012, 120:538-51. 10.1182\/blood-2012-01-380139","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.253062","article-title":"Chronic lymphocytic leukaemia and prolymphocytic leukaemia. Two coins or two sides of the same coin?","volume":"105","author":"Magnano L","year":"2020","unstructured":"Magnano L, Navarro A, L\u00f3pez-Guerra M, et al.. Chronic lymphocytic leukaemia and prolymphocytic leukaemia. Two coins or two sides of the same coin?. Haematologica. 2020, 105:e484. 10.3324\/haematol.2020.253062","journal-title":"Haematologica"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001187","article-title":"Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53","volume":"134","author":"Chapiro E","year":"2019","unstructured":"Chapiro E, Pramil E, Diop M, et al.. Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53. Blood. 2019, 134:1821-31. 10.1182\/blood.2019001187","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401644","article-title":"Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL)","volume":"14","author":"Lens D","year":"2000","unstructured":"Lens D, Matutes E, Catovsky D, Coignet LJ. Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL). Leukemia. 2000, 14:427-30. 10.1038\/sj.leu.2401644","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-115085","article-title":"Genetic characterization of B-cell prolymphocytic leukemia (B-PLL): a hierarchical prognostic model involving MYC and TP53 abnormalities. On Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group","volume":"132","author":"Chapiro E","year":"2018","unstructured":"Chapiro E, Roos-Weil D, Bougacha N, et al.. Genetic characterization of B-cell prolymphocytic leukemia (B-PLL): a hierarchical prognostic model involving MYC and TP53 abnormalities. On Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group. Blood. 2018, 132:943. 10.1182\/blood-2018-99-115085","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-020-00902-9","article-title":"Effective upfront treatment with low-dose ibrutinib for a patient with B cell prolymphocytic leukemia","volume":"38","author":"Oka S","year":"2020","unstructured":"Oka S, Ono K, Nohgawa M. Effective upfront treatment with low-dose ibrutinib for a patient with B cell prolymphocytic leukemia. Invest New Drugs. 2020, 38:1598-600. 10.1007\/s10637-020-00902-9","journal-title":"Invest New Drugs"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2016.10.006","article-title":"Flow cytometric detection of minimal residual disease in B-lineage acute lymphoblastic leukemia by using \"MRD lite\" panel","volume":"73","author":"Chatterjee T","year":"2017","unstructured":"Chatterjee T, Somasundaram V. Flow cytometric detection of minimal residual disease in B-lineage acute lymphoblastic leukemia by using \"MRD lite\" panel. Med J Armed Forces India. 2017, 73:54-7. 10.1016\/j.mjafi.2016.10.006","journal-title":"Med J Armed Forces India"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2017.04.002","article-title":"Treatment of Del17p and\/or aberrant TP53 chronic lymphocytic leukemia in the era of novel therapies","volume":"11","author":"Rafei H","year":"2018","unstructured":"Rafei H, Kharfan-Dabaja MA. Treatment of Del17p and\/or aberrant TP53 chronic lymphocytic leukemia in the era of novel therapies. Hematol Oncol Stem Cell Ther. 2018, 11:1-12. 10.1016\/j.hemonc.2017.04.002","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.11.021","article-title":"Allogeneic hematopoietic cell transplant for prolymphocytic leukemia","volume":"16","author":"Kalaycio ME","year":"2010","unstructured":"Kalaycio ME, Kukreja M, Woolfrey AE, et al.. Allogeneic hematopoietic cell transplant for prolymphocytic leukemia. Biol Blood Marrow Transplant. 2010, 16:543-7. 10.1016\/j.bbmt.2009.11.021","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/325094-a-rare-case-of-b-cell-prolymphocytic-leukemia-the-first-documented-diagnosis-in-georgia-with-a-comprehensive-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T13:04:17Z","timestamp":1735823057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/325094-a-rare-case-of-b-cell-prolymphocytic-leukemia-the-first-documented-diagnosis-in-georgia-with-a-comprehensive-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.76787","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,2]]}}}